Eisai Co., Ltd.

¥4,858As of Sun 8 Nov 2026, 12:00 UTC
TSE:4523Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (0.72%)
Div yield 3.29%
ROE 4.96%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.15)
PE TTM 32.35
TSR TTM 9.83%
Mkt cap ¥1.369T
ROIC 5.32%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5,254
8.15%
(32.26%)
Hold 12|11|7|8|0
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
103.25
109.44
105.18
104.90
6.77%
4.70%
1.53%
3.09%
Revenue¥B
139.2
142.7
144.4
150.3
0.79%
(0.25%)
(0.22%)
5.05%
Peers (US$8.695B)
Cap (US$)
PE
16.11B
10.50x
5.235B
16.68x
1.766B
9.215x
8.673B
17.73x
Capital
TTM
5Y
10Y
Leveragex
2.574
(0.889)
(0.897)
EBIT/Intx
12.19
0.181
0.206
Own earn%
(194.07)
61.95
52.47
Sh yield%
42.16
53.45
51.37
Owners
Insiders/Inst%
4.51
29.27
Short interest%
3.33
SBC / revenue%
3.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
8–15
$1 testx
0.0
Incr. ROIC%
14